The NRF2 pathway as potential biomarker for dimethyl fumarate treatment in multiple sclerosis

OBJECTIVE: Immunological studies have demonstrated a plethora of beneficial effects of dimethyl fumarate (DMF) on various cell types. However, the cellular and molecular targets are incompletely understood and response markers are scarce. Here, we focus on the relation between nuclear factor (erythr...

Descripción completa

Detalles Bibliográficos
Autores principales: Hammer, Anna, Waschbisch, Anne, Kuhbandner, Kristina, Bayas, Antonios, Lee, De‐Hyung, Duscha, Alexander, Haghikia, Aiden, Gold, Ralf, Linker, Ralf A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5989754/
https://www.ncbi.nlm.nih.gov/pubmed/29928650
http://dx.doi.org/10.1002/acn3.553

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5989754/
https://www.ncbi.nlm.nih.gov/pubmed/29928650
http://dx.doi.org/10.1002/acn3.553

Ejemplares similares